Histological and molecular studies have revealed altered expression and distribution patterns of NKCC1 and KCC2 in the dysplastic neurons of patients with FCD exhibiting epilepsy (Aronica et al., 2007; Munakata et al., 2007; Sen et al., 2007). The gene discussed is SLC12A2; the disease is epilepsy.